We'll explore new trial-backed treatment options from recent ASCO findings while busting persistent myths about who qualifies for clinical trials and when.
Zoom Link Sent Upon Registration
Tuesday, November 3, 2026 8pm ET/5pm PT

Bonus for our Embrace Community: We invite members of our Embrace community, those facing metastatic breast cancer or advanced ovarian cancer, to stay on at the end of the webinar for an intimate breakout session with our expert and Bonnie Beckoff, Director of Sharsheret Support Services.
Speaker Bio:
Dr. Roussos Torres is an Assistant Professor of Medicine in the Division of Medical Oncology at Keck School of Medicine at USC. She is a physician scientist whose clinical focus as a medical oncologist is focused in breast cancer. Dr. Roussos Torres’ research focus is in tumor immunology and immunotherapy. Dr. Roussos Torres is the Co-Leader of the Tumor Immune Microenvironment Program at the Norris Comprehensive Cancer Center and she runs a translational research program which includes basic science research aimed at identifying mechanisms to control innate immune response in breast cancer and clinical trials with the goal of broadening response to checkpoint inhibition across different stages of disease. Dr. Roussos Torres is passionate about training the next generation of translational researchers and improving patient outcomes.
Questions? Contact Melissa Rosen at [email protected].
With support from:

![]()


The Embrace Breakout Session is sponsored by:
*Disclaimer:
